Allotment of equity shares pursuant to conversion of warrants
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has allotted new equity shares following the conversion of warrants into shares. This means holders of previously issued warrants have now exercised their right to convert those warrants into actual equity shares of the company. The allotment results in an increase in the company's total outstanding share count. Specific details on the number of warrants converted, conversion price, and dilution percentage are not provided in the headline. Existing shareholders may see a marginal dilution of their ownership stake due to the issuance of these new shares.
Minor dilution expected for existing shareholders as the equity base expands. The conversion of warrants (often issued to promoters or strategic investors at a pre-set price) typically brings in capital already committed earlier, and is usually a procedural completion rather than fresh fundraising.